Affiliation:
1. Desai Sethi Urology Institute, University of Miami Miller School of Medicine , Miami, FL , USA
2. Department of Clinical Sciences, Florida State University College of Medicine , Tallahassee, FL , USA
Abstract
ABSTRACT
Background
Platelet Rich Plasma (PRP) is a novel therapy rich in growth factors and cytokines used to target the underlying causes of erectile dysfunction (ED). It is not known, however, if the composition of growth factors in PRP varies between men.
Aim
To evaluate PRP growth factor variability among men with ED.
Methods
Whole blood was collected from 8 participants with at least a 6-month history of ED. Seven men with Peyronie’s disease and 1 healthy male (without sexual dysfunction) were used as the control group. PRP was extracted from whole blood using the Arthrex Angel system. A Human Growth Factor Antibody Array for 41 proteins was performed using 3 participants and the healthy control. Using all 16 samples, quantitative detection of factors from the array that were decreased by 1.5-fold were validated with western blot.
Outcomes
From the growth factor array, 2 growth factors—granulocyte-macrophage colony stimulating factor and transforming growth factor-β were identified as having a 1.5-fold decrease between the participants and the control. Vascular endothelial growth factor (VEGF) was selected because androgens can upregulate VEGF production. Other than a weak negative correlation between VEGF expression and age, we found no correlation between growth factor expression for granulocyte-macrophage colony stimulating factor or transforming growth factor-β and age, body mass index, or comorbidities.
Clinical Translation
PRP growth factor concentration appears to vary among men with ED. PRP treatment for ED may need to be personalized for patients, depending on individual growth factor concentration.
Strengths and Limitations
This study demonstrates the variability in PRP growth factors among men with ED. This is an important finding in the investigation of PRP as a restorative treatment option for men with ED. Our study, however, was limited by a small sample size.
Conclusion
PRP growth factors vary among men with ED.
Publisher
Oxford University Press (OUP)
Subject
Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health
Reference17 articles.
1. Current diagnosis and management of erectile dysfunction;McMahon;Med J Aust,2019
2. Platelet-rich plasma injections for erectile dysfunction and Peyronie’s disease: A systematic review of evidence;Alkandari;Sex Med Rev,2021
3. Restorative therapies for erectile dysfunction: Position statement from the Sexual Medicine Society of North America (SMSNA);Liu;Sex Med,2021
4. The Angel® cPRP System for customized cellular concentrations of platelet-rich plasma;Arthrex,2019
5. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects;World Medical Association;JAMA,2013
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献